Supernus Announces Promising Interim Data from Ongoing Open-

Supernus Announces Promising Interim Data from Ongoing Open-Label Phase 2a Study of SPN-817 in Epilepsy

Supernus Announces Promising Interim Data from Ongoing Open-Label Phase 2a Study of SPN-817 in Epilepsy
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Timothyc Dec , Peter Vozzo , Jack Khattar , Jacka Khattar , Drug Administration , Supernus Pharmaceuticals Inc , Supernus Pharmaceuticals , Exchange Commission , Company Investor Relations , Nasdaq , Securities Exchange , Announces Promising Interim Data , Ongoing Open Label Phase , Investor Relations , Orphan Drug , Dravet Syndrome , Lennox Gastaut Syndrome , Percent Change , Clinical Global Impression Severity , Private Securities Litigation Reform Act , Securities Exchange Act , Senior Vice President ,